文献速递心力衰竭与心肌病血脂与心血管预防

1990至2021年中国酒精性心肌病负担、趋势与性别差异

[Burden, trends and gender disparities of alcoholic cardiomyopathy in China from 1990 to 2021].
PubMed 文献 · Zhonghua Xin Xue Guan Bing Za Zhi · 2026-01-01

基于全球疾病负担2021数据库分析中国酒精性心肌病负担。1990至2021年患病率年均增4.96%,负担呈先升后稳趋势,中年男性负担最高。

要点

  • 2021年中国酒精性心肌病患病率1.98/10万,为1990年的4.1倍,死亡率0.13/10万。
  • 1990至2021年患病率年均增4.96%,2000至2004年年增幅达峰值15.73%。
  • 45至54岁患病数峰值,50至59岁死亡与DALYs峰值,男性负担显著高于女性。

核心结论

  • 1990至2021年中国酒精性心肌病疾病负担增长显著,由流行病学因素、人口老龄化及人口增长共同驱动。
  • 中年及中老年男性为高负担人群,需针对性加强酒精摄入干预和重点人群健康管理。

研究设计与样本

  • 基于2021年全球疾病负担研究数据库提取中国酒精性心肌病患病人数、死亡人数和DALYs等指标。
  • 按年龄和性别分层分析负担指标,采用Joinpoint回归模型计算年度百分比变化,并行分解分析归因于人口增长、老龄化和流行病学因素。

主要发现

  • 对应率分别为每10万人1.98(95%UI 1.56至2.46)、0.13(95%UI 0.02至0.21)和4.55(95%UI 0.89至7.23)。
  • 2021年患病率为1990年的4.1倍,死亡率和DALYs率分别为1990年的3.3倍和2.8倍。
  • 1990至2021年患病率、死亡率及DALYs率的平均年度百分比变化分别为4.96%(95%CI 4.67%至5.25%)、3.94%(95%CI 3.63%至4.24%)和3.65%(95%CI 3.36%至3.93%),整体先升后稳。
  • 负担与年龄呈倒U型,患病数与患病率峰值在45至54岁,死亡数与DALYs峰值在50至59岁;90岁以下各年龄段男性负担均高于女性,整体患病率、死亡率、DALYs率分别为女性7.4倍、7.7倍、12.1倍。

临床怎么用

  • 关注中年及中老年男性酒精性心肌病高负担,强化酒精摄入干预和健康管理。
  • 针对患病率2000至2004年、死亡率2004至2011年、DALYs 2005至2009年的峰值时段特征,优化防控政策落实。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objectives: To analyze the burden level, temporal trends, and gender and age disparities of alcoholic cardiomyopathy (ACM) in China from 1990 to 2021. Methods: Data were extracted from the Global Burden of Disease 2021 study database. Core metrics for ACM in China-including prevalent cases, deaths, and disability-adjusted life years (DALYs)-were extracted. The absolute numbers, rates (per 100 000 population), and variation characteristics of the above mentioned disease burden parameters were analyzed by stratification according to age and gender. The Joinpoint regression model was employed to calculate the estimated annual percentage change and average annual percentage change for analyzing the segmented trends of disease burden. Decomposition analyses were conducted to attribute the changes in disease burden to three independent factors: population growth, population aging, and changes in epidemiological rates, so as to quantify the absolute contribution value and relative contribution ratio of each factor to the changes in disease burden. Results: In 2021, the number of prevalent cases of ACM in China was 28 103 (95% uncertainty interval (UI) 22 175-34 991), the number of deaths was 1 861 (95%UI 318-2 987), and the DALYs reached 64 746 person-years (95%UI 12 595-102 876 person-years). The corresponding rates were 1.98 (95%UI 1.56-2.46), 0.13 (95%UI 0.02-0.21), and 4.55 (95%UI 0.89-7.23) per 100 000 population, respectively. The prevalence of ACM in China in 2021 was 4.1-fold of that in 1990, while the mortality and DALYs rates were 3.3-fold and 2.8-fold of those in 1990, respectively. From 1990 to 2021, the average annual percentage change of prevalence, mortality, and DALY rate of ACM were 4.96% (95% confidence interval (CI) 4.67%-5.25%), 3.94% (95%CI 3.63%-4.24%), and 3.65% (95%CI 3.36%-3.93%), respectively, showing an overall trend of initial increase followed by stabilization. Specifically, the annual percentage change peaked at 15.73% (95%CI 14.51%-16.96%) for prevalence during 2000-2004, 8.42% (95%CI 7.89%-8.96%) for mortality during 2004-2011, and 9.80% (95%CI 8.72%-10.89%) for DALYs during 2005-2009. The disease burden exhibited an inverted U-shaped distribution with age. The peaks of case number and prevalence emerged in the 45-54 years age group, whereas the peaks of death number and DALYs occurred in the 50-59 years age group. Across all age groups under 90 years, males bore a higher burden of ACM in terms of prevalence, mortality, and DALYs than females, with the overall prevalence, mortality, and DALY rate being 7.4-fold, 7.7-fold, and 12.1-fold those of females, respectively. Decomposition analysis revealed that epidemiological factors were the primary driver of changes in the burden of ACM in China (contribution ratio: 43.56%-67.17%), followed by population aging (19.98%-33.56%) and population growth (12.84%-22.88%). Conclusions: From 1990 to 2021, the disease burden of ACM in China increased significantly, driven jointly by epidemiological factors, population aging and population growth, with marked disparities in gender and age distribution. Middle-aged and elderly males were identified as the high-burden population. Targeted interventions for alcohol intake, strengthened health management of key populations, and effective implementation of prevention and control policies are urgently required to alleviate the health damage caused by this disease. 目的: 分析1990—2021年中国酒精性心肌病的疾病负担水平、时间变化趋势及性别、年龄差异。 方法: 数据来源于2021年全球疾病负担研究数据库,提取中国酒精性心肌病的患病人数、死亡人数和伤残调整寿命年(DALYs)等核心指标,按年龄、性别分层分析上述疾病负担指标的数量、率(每10万人)及变化特征。采用Joinpoint回归模型计算估计年度百分比变化和平均年度百分比变化,分析疾病负担的分段趋势;通过分解分析将疾病负担变化归因为人口增长、老龄化及流行病学三大独立因素,量化各因素对疾病负担变化的绝对贡献值与相对贡献比例。 结果: 2021年,中国酒精性心肌病的患病人数为28 103例[95%不确定区间(UI)22 175~34 991例],死亡人数为1 861例(95%UI 318~2 987例),DALYs为64 746人年(95%UI 12 595~102 876人年),对应的率分别为每10万人1.98(95%UI 1.56~2.46)、0.13(95%UI 0.02~0.21)和4.55(95%UI 0.89~7.23)。2021年中国酒精性心肌病患病率为1990年的4.1倍,死亡率和DALYs分别为1990年3.3倍和2.8倍。1990—2021年,疾病患病率、死亡率及DALYs率的平均年度百分比变化分别为4.96%(95%CI 4.67%~5.25%)、3.94%(95%CI 3.63%~4.24%)和3.65%(95%CI 3.36%~3.93%),整体呈“先上升后趋于平稳”的趋势,其中患病率在2000—2004年[15.73%(95%CI 14.51%~16.96%)]、死亡率在2004—2011年[8.42%(95%CI 7.89%~8.96%)]、DALYs在2005—2009年[9.80%(95%CI 8.72%~10.89%)]的年度百分比变化达到峰值。疾病负担与年龄分布呈“倒U型”,患病人数与患病率峰值出现在45~54岁,死亡人数与DALYs峰值位于50~59岁。90岁以下各年龄段中,男性酒精性心肌病的患病、死亡和DALYs负担均高于女性,整体患病率为女性的7.4倍,死亡率为7.7倍,DALYS率为12.1倍。分解分析显示,流行病学因素是驱动中国酒精性心肌病负担变化的首要因素(贡献占比43.56%~67.17%),其次为老龄化(19.98%~33.56%)和人口增长(12.84%~22.88%)。 结论: 1990—2021年中国酒精性心肌病疾病负担增长显著,受流行病学因素、人口老龄化及人口增长共同驱动,且存在明显的性别和年龄分布差异,中年及中老年男性为高负担人群。需针对性加强酒精摄入干预、重点人群健康管理及防控政策落实,以减轻疾病带来的健康损害。.

来源:Zhonghua Xin Xue Guan Bing Za Zhi,查看原文。版权归原作者所有。

引用

  1. Fang Z, Luo XF, Zhang YH, et al. [Burden, trends and gender disparities of alcoholic cardiomyopathy in China from 1990 to 2021]. Zhonghua Xin Xue Guan Bing Za Zhi. 2026. PMID: 41866211. doi:10.3760/cma.j.cn112148-20250513-00348

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。